Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEDACNE-2: N-Acetyl-GED-0507-34-LEVO Gel 5% in Acne Vulgaris
NCT07384208Phase 3Completed
- Sponsor
- PPM Services
- Start
- Nov 2024
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of N-acetyl-GED-0507-34-LEVO in acne vulgaris, sponsored by PPM Services. Started Nov 2024; status: completed.
02
Drugs
N-acetyl-GED-0507-34-LEVO
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT07384208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07384208.